Advertisement

Topics

Latest "Cobra Biomanufacturing" News Stories

06:05 EDT 17th July 2018 | BioPortfolio

Here are the most relevant search results for "Cobra Biomanufacturing" found in our extensive news archives from over 250 global news sources.

More Information about Cobra Biomanufacturing on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cobra Biomanufacturing for you to read. Along with our medical data and news we also list Cobra Biomanufacturing Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cobra Biomanufacturing Companies for you to search.

Showing "Cobra Biomanufacturing" News Articles 1–25 of 161

Relevant

Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products. KEELE, England–(BUSINESS WIRE)–Cobra Biologics (“Cobra”) a leading international contract development and manufacturing organisation (“CDMO”), today announced that it … Continue reading → Cet article Cobra Biolog...


Amgen Announces Rhode Island Will Be Location of First US Next-Generation Biomanufacturing Plant

NewsAmgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I. The new plant, the first of its kind in the United States, will employ Amgen's proven next-generation biomanufacturing capabilities and manufacture products for the U.S. and global markets.

Cobra awarded £2.6m from Innovate UK for expansion

Keele, UK-based Cobra Biologics is being handed £2.6 million by Innovate UK to help the firm expand and develop its infrastructure.


$160M biomanufacturing plant planned in R.I.

California-based biotech firm Amgen is planning to build a $160 million biomanufacturing plant in Rhode Island.  -More- 

Amgen to build new biomanufacturing plant in Rhode Island, US

Amgen has announced it is building a ‘next-generation’ biomanufacturing plant at its West Greenwich campus in Rhode Island. The first...Read More... The post Amgen to build new biomanufacturing plant in Rhode Island, US appeared first on Pharmaceutical Technology.

Amgen: Tax reforms stoke $300m investment in next-gen US biomanufacturing plant

Amgen has announced plans for a US biomanufacturing facility, similar to its flexible and single-use Singapore plant, as part of $3.5bn freed through tax reforms.

Amgen picks Rhode Island location for next-gen biomanufacturing

Rhode Island will be the home of Amgenâs first US next-generation biomanufacturing plant, based on the firmâs modular, single-use site in Singapore.

Cobra Biologics and Symbiosis granted £1.9 million from Innovate UK

International CDMO of biologics and pharmaceuticals, Cobra Biologics, and CMO specialising in sterile fill finish, Symbiosis Pharmaceutical Services, have been awarded a collaborative grant of £1.9 million from Innovate UK.

GE to provide biomanufacturing platform for Clover’s Chinese facility

GE Healthcare will provide its biomanufacturing platform for Clover Biopharmaceuticals’ new production facility in China.

WuXi Biologics To Build Largest Biomanufacturing Facility Using Single-Use Bioreactors In Ireland

NewsWuXi will invest $392M to build the facility, which will deploy multiple single-use bioreactors for commercial biomanufacturing and is also designed to be able to run continuous bioprocessing.

Cobra Biologics Awarded with Bionow Project of the Year 2016

Celebrating the crème-de-la-crème of life sciences talent in the North of England and sponsored by Manchester Science Partnerships, the awards ceremony recognised the biomedical industry’s highest achievers. Around 400 people attended the gala dinner at The Mere Golf Resort and Spa, Cheshire, hosted by comedian and broadcaster Paul Sinha, one of the stars of the ITV quiz The Chase. The team at...

Series B equity financing round closes at €16 million to support development of biomanufacturing tech

Tech company, Univercells, and Global Health Investment Fund (GHIF) have announced the closing of a €16 million Series B equity financing round, which will support the continued development of Univercell’s biomanufacturing technology.

WuXi Biologics to build €325m biomanufacturing facility in Ireland

China-based WuXi Biologics is set to construct a biologics drug substance manufacturing facility worth about €325m in Dundalk, Ireland. The...Read More... The post WuXi Biologics to build €325m biomanufacturing facility in Ireland appeared first on Pharmaceutical Technology.

WuXi Biologics to Build Biomanufacturing Facility in Ireland

WuXi Biologics is to invest $392 million to build a new biologics drug substance manufacturing facility in Ireland. The new facility will use single-use bioreactors for commercial biomanufacturing. This is also WuXi Biologics’ first manufacturing site outside of China. A total of 48,000 L fed-batch and 6,000 L perfusion bioreactor capacity will be installed. This facility will create approxi...

Cobra Biologics and The University of Manchester Announce Collaboration to Improve Industrial Scale-up

Keele and Manchester, UK, 24 September 2015: Cobra Biologics, international CDMO of biologics and pharmaceuticals, and Alan Dickson, Professor of Biotechnology at The University of Manchester (UoM) today announced a two year collaboration focused on improving understanding of cellular bioprocessing required for the scaled production of therapeutic proteins. The collaboration is supported via the F...

Amgen to invest $160M in biomanufacturing facility

Cobra Biologics Wins ‘CMO Leadership Award’ for Expertise, Quality and Service

The CMO Leadership Awards are organised by Life Science Leader magazine and recipients determined through customer feedback collected by Industry Standard Research (ISR). For the 2018 awards, which will be presented at a reception dinner at The W Hotel in New York City on March 21, more than 110 contract manufacturers were assessed by 23 performance metrics in ISR’s annual Contract Manufactu...

Cobra Biologics Awarded $3.4M by Innovate UK

As part of a strategy boost for UK medicines with £70 million of funding

Cobra & Symbiosis Receive Collaborative Grant

Innovate UK awarded the companies £1.9m for the development of advanced therapies

VIDEO: Cobra & Symbiosis Receive Collaborative Grant

Innovate UK awarded the companies £1.9m for the development of advanced therapies

Horizon Discovery Partners for Immuno-oncology

To support the development and manufacture of a novel biomanufacturing cell line for commercial use

Cobra Biologics awarded £2.6m ($3.4m USD) from Innovate UK

Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments Keele, UK, 23 January 2018: Cobra Biologics (Cobra), an international CDMO of biologics and pha...

Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade in the export of services for gene and immunotherapy products

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products. 21 April 2018, Keele, UK: Cobra Biologics (“Cobra”) a leading international contract development and manufacturing organisation (“CDMO”), today announced that it has been awarded the Queen’s Award 2018 f...

Cobra and Tecrea Awarded £112K Innovate UK Grant to Develop AAV Scalable Production Bioprocess

Cobra Biologics and Tecrea, a cell delivery biotechnology company, have been awarded a 15 month collaborative grant of £112,291 ($166,000 USD) by the UK’s innovation agency, Innovate UK for the development of a scalable Adeno Associated Virus (AAV) production bioprocess.The grant is awarded under Innovate UK’s ‘Technology Inspired Innovation’ competition, which aims t...

Amgen to Build First U.S Next-Gen Bio-Mfg. Plant

New $160-million biomanufacturing plant in RI to create 150 additional highly-skilled jobs


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks